Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease-Reference-Cited by-同舟云学术

Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease

Published:2019-10 Issue:43 Volume:37 Page:6558-6565
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Vestjens Stefan M.T.^ORCID,Sanders Elisabeth A.M.,Vlaminckx Bart J.,de Melker Hester E.,van der Ende Arie,Knol Mirjam J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference26 articles.

1. European Centre for Disease Prevention and Control (ECDC). Disease factsheet about pneumococcal disease n.d. (accessed December 7, 2018).

2. World Health Organization (WHO). Vaccines and diseases|Pneumococcal disease 2014.

3. European Centre for Disease Prevention and Control (ECDC). Vaccine schedules in all countries of the European Union n.d. (accessed April 11, 2018).

4. World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system. 2018 global summary 2018. (accessed December 7, 2018).

5. National Institute for Public Health and the Environment (RIVM). Immunisation coverage and annual report National Immunisation Programme in the Netherlands 2017 2018. (accessed December 7, 2018).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance;Vaccine;2024-04

2. Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands;BMC Medicine;2024-02-16

3. Long-term surveillance of invasive pneumococcal disease: The impact of 10-valent pneumococcal conjugate vaccine in the metropolitan region of Salvador, Brazil;Vaccine;2024-01

4. Antimicrobial Resistance of Streptococcus pneumoniae Clinical Serotypes between 2017 and 2022 in Crete, Greece;Infection & Chemotherapy;2024

5. Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands;Infectious Diseases and Therapy;2023-06-15